GO:0140656 endodeoxyribonuclease activator activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0140656 (endodeoxyribonuclease activator activity) is a molecular function describing proteins that bind to and increase the catalytic activity of an endodeoxyribonuclease.
• The best-characterized activator system is Sae2/CtIP, which stimulates the Mre11-Rad50-Xrs2 (MRX) complex to cleave DNA ends during homologous recombination and DNA damage repair.
• Activators can work by promoting endonuclease subunit assembly, stabilizing a catalytically competent conformation, or relieving autoinhibition of the nuclease.
• Dysregulation of endodeoxyribonuclease activator activity is linked to genome instability, defective meiosis, and cancer predisposition, as shown for BRCA1-dependent checkpoint control and CtIP-MRN biology.
• CRISPR-Cas12a effectors are also regulated by activator-like mechanisms, including RNA-triggered dsDNA destruction by Cas12a2 and padlock-based inhibition of trans-cleavage.
• Studying this activity requires combining structural biology, nuclease assays, and CRISPR-based perturbation of activator genes such as SAE2/CTIP, MRE11, RAD50, and BRCA1.
Description
GO:0140656, endodeoxyribonuclease activator activity, defines a molecular function in which a protein binds to an endodeoxyribonuclease and increases its ability to cleave DNA internally. This activity is distinct from the nuclease catalytic activity itself: the activator is not the enzyme that hydrolyzes the phosphodiester bond, but a regulatory partner that licenses, stabilizes, or stimulates the nuclease. In eukaryotic cells, the archetypal example is Sae2 in budding yeast and its mammalian ortholog CtIP, which activate the Mre11-Rad50-Xrs2 (MRX) or MRN complex to resect DNA double-strand breaks. Because endonucleolytic cleavage is a committed step in DNA repair, recombination, and genome maintenance, activator proteins are critical nodes for understanding how cells preserve genomic integrity. The importance of GO:0140656 extends beyond classical DNA repair. Recent work shows that CRISPR-associated nucleases such as Cas12a2 can be triggered by RNA to destroy dsDNA, illustrating how activator-like inputs can switch a nuclease from inactive to active states. Engineered Cas12a variants with increased activity further demonstrate that nuclease output can be tuned by protein-level changes that mimic activator effects. In parallel, the caspase-activated DNase (CAD) drives inflammation and antiviral defense, and its regulation depends on activator/inhibitor balance. Thus, endodeoxyribonuclease activator activity is a general principle in nuclease control, relevant to DNA repair, immunity, and genome engineering. For researchers, GO:0140656 provides a precise annotation target when studying proteins that are neither nucleases nor simple binding partners but true positive regulators of endonucleolytic function. Assigning this term helps distinguish direct activation from downstream transcriptional or pathway effects, and it guides experimental design toward reconstituted nuclease assays, structural analysis, and CRISPR perturbation of activator genes.
endodeoxyribonuclease activator activity At A Glance
| GO ID | GO:0140656 |
|---|---|
| GO term | endodeoxyribonuclease activator activity |
| Ontology | molecular_function |
| Synonym | none |
| Definition | Binds to and increases the activity of an endodeoxyribonuclease. |
| Major function | Positive regulation of endodeoxyribonuclease catalytic activity, often in DNA repair and recombination. |
| Representative activators | Sae2 (yeast), CtIP (mammalian), and related cofactors of Mre11-Rad50 complexes. |
| Representative target nucleases | Mre11-Rad50-Xrs2 (MRX) / MRN complex endonuclease. |
| Related processes | DNA double-strand break resection, homologous recombination, meiosis, genome stability. |
| Disease relevance | Genome instability, cancer predisposition, and defective DNA damage responses. |
What Is GO:0140656?
In our own words, endodeoxyribonuclease activator activity (GO:0140656) is the function of a protein that physically binds to an endodeoxyribonuclease and increases its enzymatic activity. The activator does not necessarily cleave DNA itself; instead, it enhances the nuclease's ability to introduce internal cuts in DNA. This can occur through promoting complex assembly, stabilizing a catalytically active conformation, or relieving autoinhibition. The term is a molecular function annotation and is supported by biochemical and structural evidence for activator-nuclease pairs such as Sae2/CtIP and the Mre11-Rad50 complex.
Why Is endodeoxyribonuclease activator activity Important in Cell Biology?
Endodeoxyribonuclease activator activity is important because it controls the initiation of DNA end processing, a decisive step in DNA double-strand break repair and recombination. Without proper activation of nucleases such as Mre11-Rad50, cells fail to resect DNA ends, leading to defective homologous recombination and reliance on error-prone repair pathways. This has direct implications for cancer biology, since BRCA1 and CtIP-dependent functions safeguard genome integrity and eliminate recombination-defective oocytes. Moreover, understanding activator mechanisms informs CRISPR nuclease engineering, where activity-enhancing mutations and activator-like triggers can expand targeting ranges and applications.
• Controls the committed step of DNA end resection during homologous recombination.
• Determines whether double-strand breaks are repaired accurately or through error-prone mechanisms.
• Supports meiotic recombination and chromosome synapsis checkpoints, as shown for BRCA1.
• Protects genome integrity and prevents cancer-associated genomic instability.
• Provides a mechanistic framework for engineering CRISPR nucleases with altered activity.
• Links nuclease regulation to innate immunity and inflammation through CAD and Cas12a2 systems.
• Offers targets for synthetic biology tools that switch nucleases on or off.
• Guides interpretation of variants in SAE2/CTIP, MRE11, RAD50, and BRCA1 in clinical genetics.
• Enables development of biosensors and diagnostics based on controlled nuclease activation.
• Connects structural biology of MRX/MRN to functional outcomes in cells and organisms.
What Happens During endodeoxyribonuclease activator activity?
Recognition and binding of the endodeoxyribonuclease
In simple terms: The activator first finds and attaches to the nuclease enzyme.
The activator protein recognizes its target endodeoxyribonuclease, often as part of a larger repair complex. For Sae2/CtIP, binding to the Mre11-Rad50 complex is a prerequisite for stimulating endonucleolytic cleavage near DNA ends. Structural and functional studies show that the activator makes specific contacts with the nuclease and its DNA substrate, positioning the complex for catalysis.
Conformational activation of the nuclease
In simple terms: Binding flips the nuclease into an active shape.
Once bound, the activator induces or stabilizes a catalytically competent conformation of the endodeoxyribonuclease. Molecular insights into Sae2/CtIP-mediated activation of Mre11-Rad50 endonuclease activity reveal that the activator promotes rearrangements that relieve autoinhibition and align catalytic residues with the DNA backbone. The Sae2 C-terminus contributes additional interactions that are required for full MRX endonuclease activation.
Stimulation of DNA endonucleolytic cleavage
In simple terms: The activated nuclease cuts DNA internally.
After activation, the endodeoxyribonuclease introduces internal cuts in DNA, generating resected ends that are essential for homologous recombination. This step is tightly coupled to cell-cycle signals and checkpoint control, as illustrated by BRCA1-dependent elimination of recombination-defective oocytes. The activator itself does not necessarily cleave DNA; its role is to increase the nuclease's catalytic output.
Downstream processing and repair pathway choice
In simple terms: The cut ends are further processed, deciding how the break is repaired.
The cleavage products generated by activator-stimulated nucleases feed into downstream resection and repair machinery. Proper activation favors homologous recombination, whereas failure of activation shifts repair toward non-homologous end joining or other error-prone pathways. This pathway choice has direct consequences for genome stability and is influenced by checkpoint proteins such as BRCA1.
Regulation by activator availability and modification
In simple terms: The cell controls when and where the activator works.
Activator activity is regulated by expression levels, post-translational modifications, and cell-cycle-dependent localization. Sae2/CtIP function is coordinated with CDK-dependent phosphorylation and checkpoint signaling, ensuring that endonucleolytic activation occurs at the right time and place. In parallel, nuclease systems such as Cas12a2 are controlled by RNA triggers that switch on dsDNA destruction, illustrating diverse activation logic.
Key Genes Involved in GO:0140656 endodeoxyribonuclease activator activity
The following genes and proteins are central to the study of endodeoxyribonuclease activator activity, based on their established roles in nuclease activation, DNA repair, and related regulatory systems.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SAE2 (yeast) | Activator of MRX endonuclease | Model for mechanistic studies of endodeoxyribonuclease activator activity. |
| CTIP (mammalian) | Ortholog of Sae2; activates MRN endonuclease | Key regulator of DNA end resection and homologous recombination. |
| MRE11 | Catalytic subunit of MRX/MRN nuclease | Target of activator binding and conformational regulation. |
| RAD50 | Structural and regulatory subunit of MRX/MRN | Required for activator-dependent nuclease stimulation. |
| XRS2 (yeast) | Accessory subunit of MRX | Supports complex assembly and activator function. |
| NBN (NBS1) | Accessory subunit of MRN in mammals | Coordinates activator-dependent resection with checkpoint signaling. |
| BRCA1 | Checkpoint and recombination regulator | Safeguards genome integrity and eliminates recombination-defective oocytes. |
| CAS12A2 | RNA-triggered dsDNA nuclease | Example of activator-like triggering of nuclease activity. |
| CAS12A | RNA-guided DNA nuclease | Engineered variants show increased activity and targeting range. |
| CAD (DFFB) | Caspase-activated DNase | Drives inflammation and antiviral defense; regulated by activator/inhibitor balance. |
| DNASE1 | Secreted endodeoxyribonuclease | Target of dual-active variants for NET degradation. |
| DNASE1L3 | Endodeoxyribonuclease family member | Related to DNASE1 in extracellular DNA clearance. |
| PADLOCK-like activators | Synthetic regulators of Cas12a | Inhibit trans-cleavage, showing tunable nuclease control. |
| ATM | DNA damage checkpoint kinase | Coordinates responses downstream of nuclease activation. |
| CDK1/CDK2 | Cell-cycle kinases | Phosphorylate CtIP/Sae2 to regulate activation timing. |
| RAD51 | Recombinase | Acts downstream of activator-driven resection. |
| EXO1 | Exonuclease | Functions in long-range resection after initial endonucleolytic cuts. |
How Is endodeoxyribonuclease activator activity Regulated?
Endodeoxyribonuclease activator activity is regulated at multiple levels. Cell-cycle-dependent phosphorylation of Sae2/CtIP by CDK kinases controls its ability to stimulate MRX/MRN endonuclease activity. Checkpoint kinases such as ATM influence the timing and extent of resection, linking activator function to DNA damage signaling. In addition, activator availability, localization, and interaction partners determine whether the nuclease is switched on. In CRISPR systems, RNA triggers and synthetic inhibitors provide additional layers of control over nuclease activity.
endodeoxyribonuclease activator activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| BRCA1 | Cancer predisposition, meiotic failure | BRCA1 knockout or point-mutation cell lines; oocyte models. |
| CTIP | Genome instability, defective resection | CTIP knockout and knock-in cells; nuclease assays. |
| MRE11 | DNA repair disorders, cancer | MRE11 point-mutation knock-in; MRX reconstitution. |
| CAD (DFFB) | Inflammation, antiviral defense | CAD knockout macrophages; infection models. |
| DNASE1 | Autoimmunity, NET-associated pathology | DNASE1 variant overexpression; NET degradation assays. |
Cancer and genome instability
Defects in endodeoxyribonuclease activator activity can impair DNA end resection, forcing cells to use error-prone repair and promoting genome instability. BRCA1-dependent checkpoint control eliminates recombination-defective oocytes, and loss of such safeguards is associated with cancer predisposition. CtIP-MRN activation is therefore central to understanding how cells avoid mutations that drive tumorigenesis.
Meiotic failure and infertility
Activator-dependent nuclease function is required for meiotic recombination. BRCA1 safeguards genome integrity by activating a chromosome asynapsis checkpoint to eliminate recombination-defective oocytes, linking activator biology to fertility and meiotic quality control.
Inflammation and antiviral defense
The caspase-activated DNase (CAD) drives inflammation and contributes to defense against viral infection, illustrating how endodeoxyribonuclease regulation impacts immune responses. Similarly, Cas12a2 elicits abortive infection through RNA-triggered destruction of dsDNA, showing that nuclease activation is a conserved theme in immunity.
Autoimmune and extracellular DNA clearance
DNASE1 and related enzymes degrade extracellular DNA, and dual-active DNase1 variants have been developed to target neutrophil extracellular traps (NETs). Although these enzymes are not classical activator proteins, their regulation highlights the therapeutic importance of controlling endodeoxyribonuclease activity in inflammatory and autoimmune contexts.
From endodeoxyribonuclease activator activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of the activator abolish nuclease activity? | Knockout of SAE2/CTIP in yeast or mammalian cells. |
| Which residues mediate activator-nuclease contact? | Point mutations in activator or nuclease followed by biochemical assays. |
| Can a tagged activator be tracked in live cells? | Knock-in of fluorescent or epitope tags at the endogenous locus. |
| Does overexpression of the activator increase resection? | Overexpression cell lines and DNA end resection assays. |
| Can synthetic activators switch on Cas12a? | Engineered Cas12a variants and activator-like molecules. |
| Does activator loss alter immune DNA degradation? | CAD or DNASE1 knockout/overexpression in immune cells. |
How to Study the endodeoxyribonuclease activator activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| In vitro nuclease assay | Stimulation of endodeoxyribonuclease cleavage | Testing activator-nuclease pairs. |
| Cryo-EM | Structural changes induced by activator binding | Mechanistic studies of MRX/MRN activation. |
| CRISPR knockout | Loss-of-function effects on nuclease activity | Validating activator genes in cells. |
| CRISPR knock-in | Tagged or mutant activator expression | Localization and interaction studies. |
| Resection assay | DNA end processing in cells | Measuring downstream repair outcomes. |
| Reporter recombination assay | Homologous recombination efficiency | Linking activator function to repair. |
| NET degradation assay | Extracellular DNA clearance | Testing DNase1 variants. |
| Cas12a trans-cleavage assay | Nuclease activity modulation | Biosensor and inhibitor studies. |
Biochemical nuclease activation assays
Reconstituted systems using purified activator and endodeoxyribonuclease allow direct measurement of cleavage stimulation. These assays have been used to define Sae2/CtIP-dependent activation of Mre11-Rad50 endonuclease activity and to map the contribution of the Sae2 C-terminus.
Structural biology and conformational analysis
Cryo-EM and crystallography reveal how activators bind and reshape the nuclease active site. Molecular insights into Mre11-Rad50 activation by Sae2/CtIP provide a structural framework for understanding activator function.
CRISPR-based genetic perturbation
Knockout, point-mutation, and knock-in models of activator genes enable functional studies in cells. Engineered Cas12a variants with increased activity also illustrate how nuclease output can be tuned for gene, epigenetic, and base editing.
DNA damage and repair readouts
Resection assays, recombination reporters, and checkpoint activation markers measure the downstream consequences of activator activity. BRCA1-dependent checkpoint control of oocyte quality provides an in vivo example of such readouts.
How CRISPR Can Be Used to Study GO:0140656 endodeoxyribonuclease activator activity
Knockout
CRISPR knockout of activator genes such as SAE2/CTIP or MRE11 allows researchers to test whether endodeoxyribonuclease activator activity is required for DNA end resection and recombination. Loss-of-function models reveal downstream repair defects and genome instability.
Point Mutation
Point mutations in activator or nuclease interfaces can separate binding from activation. Such models are essential for mapping the residues that mediate stimulation of Mre11-Rad50 endonuclease activity.
Knock-in
Knock-in of epitope or fluorescent tags at endogenous activator loci enables real-time tracking of activator localization and complex assembly during DNA damage responses.
Overexpression
Overexpression of activators or engineered nuclease variants can enhance DNA cleavage and editing outcomes. Engineered Cas12a variants with increased activities demonstrate the power of tuning nuclease output for gene, epigenetic, and base editing.
How EDITGENE Supports endodeoxyribonuclease activator activity Research
Researchers studying endodeoxyribonuclease activator activity-related genes often need to determine whether a candidate gene is causally involved in nuclease regulation, DNA repair, or disease. Establishing causality requires precise genetic models that can separate binding, activation, and downstream repair functions. EDITGENE provides end-to-end CRISPR services to generate such models efficiently and reproducibly.
Contact EDITGENE today to design your custom CRISPR model for endodeoxyribonuclease activator activity research.
Frequently Asked Questions About endodeoxyribonuclease activator activity
What is endodeoxyribonuclease activator activity?
It is a molecular function (GO:0140656) in which a protein binds to and increases the activity of an endodeoxyribonuclease, often to promote DNA cleavage during repair or recombination.
What genes are involved in endodeoxyribonuclease activator activity?
Key genes include SAE2/CTIP, MRE11, RAD50, XRS2/NBN, and BRCA1, which form or regulate activator-nuclease complexes.
How does Sae2/CtIP activate the Mre11-Rad50 nuclease?
Sae2/CtIP binds the MRX/MRN complex and induces conformational changes that relieve autoinhibition and align the active site for DNA cleavage.
Why is endodeoxyribonuclease activator activity important for DNA repair?
It controls DNA end resection, a committed step that determines whether breaks are repaired by homologous recombination or error-prone pathways.
Is endodeoxyribonuclease activator activity linked to cancer?
Yes, defects in activator-dependent resection and checkpoint control, such as BRCA1 dysfunction, are associated with genome instability and cancer predisposition.
Can CRISPR be used to study endodeoxyribonuclease activator activity?
Yes, CRISPR knockout, point-mutation, knock-in, and overexpression models allow precise dissection of activator function in cells.
What experimental methods measure endodeoxyribonuclease activator activity?
In vitro nuclease assays, cryo-EM, resection assays, and recombination reporters are commonly used to measure activator-dependent nuclease stimulation.
Are there synthetic regulators of endodeoxyribonuclease activity?
Yes, engineered Cas12a variants and padlock-based inhibitors can tune nuclease activity, demonstrating synthetic control of related systems.
How does CAD relate to endodeoxyribonuclease regulation?
The caspase-activated DNase drives inflammation and antiviral defense, illustrating how endodeoxyribonuclease activity is controlled in immunity.
What models are best for studying activator-nuclease interfaces?
Reconstituted biochemical systems combined with point-mutation knock-in cell lines provide the most direct evidence for interface function.
Conclusion
GO:0140656 endodeoxyribonuclease activator activity captures a fundamental regulatory function that controls when and where endodeoxyribonucleases cut DNA. The Sae2/CtIP-MRX/MRN axis provides the best-characterized example, linking activator function to DNA end resection, homologous recombination, and genome stability. Beyond DNA repair, activator-like control is seen in CRISPR-Cas12a2 and CAD systems, underscoring the broad relevance of this activity. For researchers, precise genetic models are essential to move from correlation to causation. By combining CRISPR knockout, point-mutation, knock-in, overexpression, and library screening with biochemical and structural readouts, it is possible to define how activators stimulate nucleases and how their dysfunction contributes to disease.
References
- 1. Dmytrenko O et al.. 2023. Cas12a2 elicits abortive infection through RNA-triggered destruction of dsDNA.. Nature 613(7944):588-594 PMID: 36599979
- 2. Kleinstiver BP et al.. 2019. Engineered CRISPR-Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editing.. Nat Biotechnol 37(3):276-282 PMID: 30742127
- 3. Moeed A et al.. 2024. The Caspase-Activated DNase drives inflammation and contributes to defense against viral infection.. Cell Death Differ 31(7):924-937 PMID: 38849575
- 4. Bai L et al.. 2024. BRCA1 safeguards genome integrity by activating chromosome asynapsis checkpoint to eliminate recombination-defective oocytes.. Proc Natl Acad Sci U S A 121(19):e2401386121 PMID: 38696471
- 5. Nicolas Y et al.. 2024. Molecular insights into the activation of Mre11-Rad50 endonuclease activity by Sae2/CtIP.. Mol Cell 84(12):2223-2237.e4 PMID: 38870937
- 6. Colombo CV et al.. 2024. Functional and molecular insights into the role of Sae2 C-terminus in the activation of MRX endonuclease.. Nucleic Acids Res 52(22):13849-13864 PMID: 39558159
- 7. Lei X et al.. 2024. PAIT effect: Padlock activator inhibits the trans-cleavage activity of CRISPR/Cas12a.. Biosens Bioelectron 263:116607 PMID: 39067412
- 8. Englert H et al.. 2023. Targeting NETs using dual-active DNase1 variants.. Front Immunol 14:1181761 PMID: 37287977
